Quick Answer
NEOGENOMICS INC reported Research And Development Expense of $37.08 million for the year ending 2025.
- NEOGENOMICS INC showed an increase of +19.0% in Research And Development Expense from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $119.0 thousand | Q3 2011: $125.0 thousand | Q1 2012: $497.0 thousand | Q2 2012: $528.0 thousand | Q3 2012: $808.0 thousand | Q1 2013: $835.0 thousand | Q2 2013: $616.0 thousand | Q3 2013: $340.0 thousand | Q1 2014: $628.0 thousand | Q2 2014: $633.0 thousand | Q3 2014: $1.01 million | Q1 2015: $669.0 thousand | Q2 2015: $803.0 thousand | Q3 2015: $871.0 thousand | Q1 2016: $1.45 million | Q2 2016: $1.31 million | Q3 2016: $967.0 thousand | Q1 2017: $862.0 thousand | Q2 2017: $947.0 thousand | Q3 2017: $1.27 million | Q1 2018: $956.0 thousand | Q2 2018: $1.07 million | Q3 2018: $446.0 thousand | Q1 2019: $1.21 million | Q2 2019: $2.59 million | Q3 2019: $2.61 million | Q1 2020: $2.06 million | Q2 2020: $2.11 million | Q3 2020: $1.96 million | Q1 2021: $2.46 million | Q2 2021: $3.50 million | Q3 2021: $7.41 million | Q1 2022: $7.71 million | Q2 2022: $8.63 million | Q3 2022: $7.31 million | Q1 2023: $7.40 million | Q2 2023: $7.50 million | Q3 2023: $5.29 million | Q1 2024: $7.62 million | Q2 2024: $7.89 million | Q3 2024: $7.68 million | Q1 2025: $10.18 million | Q2 2025: $9.02 million | Q3 2025: $8.69 million.
- Over the full 15 years of available data (2011 to 2025), NEOGENOMICS INC's Research And Development Expense has grown by 6,728.2%.
- Historical annual values: Fiscal year 2025: $37.08 million | Fiscal year 2024: $31.16 million | Fiscal year 2023: $27.31 million | Fiscal year 2022: $30.33 million | Fiscal year 2021: $21.87 million | Fiscal year 2020: $8.23 million | Fiscal year 2019: $8.49 million | Fiscal year 2018: $3.00 million | Fiscal year 2017: $3.64 million | Fiscal year 2016: $4.65 million | Fiscal year 2015: $4.20 million | Fiscal year 2014: $2.69 million | Fiscal year 2013: $2.44 million | Fiscal year 2012: $2.28 million | Fiscal year 2011: $543.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: